C. Jamard

发表

Nucleic Acid Polymers with Accelerated Plasma and Tissue Clearance for Chronic Hepatitis B Therapy

S. Seiffert, L. Cova, Jennifer A. Lockridge, 2017, Molecular therapy. Nucleic acids.

Infection Woodchuck Model of Hepatitis B Virus Delivery of Gamma Interferon in the Emtricitabine with Adenovirus-Mediated Effect of a Combination of Clevudine and

M. Chevallier, F. Zoulim, S. Guerret, 2004 .

Effect of a Combination of Clevudine and Emtricitabine with Adenovirus-Mediated Delivery of Gamma Interferon in the Woodchuck Model of Hepatitis B Virus Infection

M. Chevallier, F. Zoulim, S. Guerret, 2004, Antimicrobial Agents and Chemotherapy.

Inhibitory Effect of Adefovir on Viral DNA Synthesis and Covalently Closed Circular DNA Formation in Duck Hepatitis B Virus-Infected Hepatocytes In Vivo and In Vitro

C. Gibbs, F. Zoulim, C. Trépo, 2002, Antimicrobial Agents and Chemotherapy.

Antiviral Activity of β-l-2′,3′-Dideoxy-2′,3′-Didehydro-5-Fluorocytidine in Woodchucks Chronically Infected with Woodchuck Hepatitis Virus

M. Chevallier, F. Zoulim, S. Guerret, 2001, Antimicrobial Agents and Chemotherapy.

In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins.

F. Zoulim, L. Cova, S. Guerret, 2012, Virology.

Duck hepatitis B virus polymerase gene mutants associated with resistance to lamivudine have a decreased replication capacity in vitro and in vivo.

F. Zoulim, C. Trépo, C. Jamard, 2001, Journal of hepatology.

Characterization of the Antiviral Effect of 2′,3′-Dideoxy-2′, 3′-Didehydro-β-l-5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model

Yung-chi Cheng, M. Chevallier, F. Zoulim, 2000, Antimicrobial Agents and Chemotherapy.

Nucleic acid polymer REP 2139 and nucleos(T)ide analogues act synergistically against chronic hepadnaviral infection in vivo in Pekin ducks

L. Cova, C. Sureau, S. Guerret, 2018, Hepatology.

Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatoma.

F. Zoulim, C. Trépo, C. Jamard, 1997, Journal of hepatology.

Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation.

F. Zoulim, L. Cova, S. Guerret, 2012, Virology.

Genetic vaccination for production of DNA-designed antibodies specific to Hepadnavirus envelope proteins.

F. Zoulim, L. Cova, B. Ndéboko, 2006, Vaccine.

Enhanced duck hepatitis B virus gene expression following aflatoxin B exposure

M. Chevallier, C. Wild, C. Borel, 1999, Hepatology.

Characterization of the Antiviral Effect of 2 9 ,3 9 -Dideoxy-2 9 , 3 9 -Didehydro- b - L -5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model

M. Chevallier, F. Zoulim, C. Trépo, 1999 .

The role of duck hepatitis B virus and aflatoxin B1 in the induction of oxidative stress in the liver.

M. Chevallier, C. Wild, J. Cadet, 2001, Cancer detection and prevention.

Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein.

C. Sunyach, C. Trépo, L. Cova, 1999, Gastroenterology.

n-Butyrate, a cell cycle blocker, inhibits early amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of duck hepatocytes

C. Borel, C. Guguen-Guillouzo, C. Trépo, 1996, Journal of virology.

The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.

F. Zoulim, C. Trépo, J. Imbach, 1999, Antiviral research.

Early life humoral response of ducks to DNA immunization against hepadnavirus large envelope protein.

C. Trépo, L. Cova, C. Rollier, 2000, Vaccine.

Maternally Transferred Antibodies from DNA-Immunized Avians Protect Offspring against Hepadnavirus Infection

C. Trépo, L. Cova, C. Rollier, 2000, Journal of virology.

Inhibitory Effect of 2′-Fluoro-5-Methyl-β-l-Arabinofuranosyl-Uracil on Duck Hepatitis B Virus Replication

M. Chevallier, F. Zoulim, C. Borel, 1998, Antimicrobial Agents and Chemotherapy.

Effects of Pyrimidine and Purine Analog Combinations in the Duck Hepatitis B Virus Infection Model

F. Zoulim, C. Trépo, C. Jamard, 2003, Antimicrobial Agents and Chemotherapy.

Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model.

C. Gibbs, M. Chevallier, F. Zoulim, 2003, Journal of hepatology.

In vivo infectivity of liver extracts after resolution of hepadnaviral infection following therapy associating DNA vaccine and cytokine genes

M. Chevallier, F. Zoulim, S. Guerret, 2013, Journal of viral hepatitis.

Role of Cell-Penetrating Peptides in Intracellular Delivery of Peptide Nucleic Acids Targeting Hepadnaviral Replication

P. Nielsen, L. Cova, B. Ndéboko, 2017, Molecular therapy. Nucleic acids.

In vivo selection of duck hepatitis B virus pre-S variants which escape from neutralization.

C. Sunyach, C. Trépo, L. Cova, 1997, Virology.

Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy

Gabriela D. A. Guardia, P. Laurent-Puig, L. O. Penalva, 2021, Cancer Research.

The murine intestinal stem cells are highly sensitive to the modulation of the T3/TRα1-dependent pathway.

L. O. Penalva, M. Plateroti, J. Freund, 2021, Development.

Lysosomal MLKL is balanced by ESCRT to control cell death

G. Ichim, M. Castets, C. Jamard, 2023, bioRxiv.